METHODS FOR AUTONOMIC NEUROMODULATION FOR THE TREATMENT OF SYSTEMIC DISEASE

• US 20100249859A1
• Filed: 06/14/2010
• Published: 09/30/2010
• Est. Priority Date: 07/23/2001
• Status: Abandoned Application

• Current Assignee: DiLorenzo Biomedical, LLC
• Original Assignee: DiLorenzo Biomedical, LLC
• Inventors: DiLorenzo, Daniel John
• Application Number:
  US12/815,094
• Publication Number:
  US 20100249859A1
• Time in Patent Office: Days
• US Class Current: 607/2
• CPC Class Codes: A61N 1/0551 Spinal or peripheral nerve electrodes
• CPC Class Codes: A61N 1/0556 Cuff electrodes
• CPC Class Codes: A61N 1/36007 of urogenital or gastrointestinal organs, e.g. for incontinence control
• CPC Class Codes: A61N 1/36082 Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease
• CPC Class Codes: A61N 1/36114 Cardiac control, e.g. by vagal stimulation stimulating the heart A61N1/362
• CPC Class Codes: A61N 2/00 Magnetotherapy
• CPC Class Codes: A61N 5/00 Radiation therapy ultrasound therapy A61N7/00; devices or apparatus applicable to both therapy and diagnosis A61B6/00
• CPC Class Codes: A61N 7/00 Ultrasound therapy lithotripsy A61B17/22, A61B17/225; massage using supersonic vibration A61H23/00 ; using ultrasound for introducing media into the body A61M37/0092

Abstract

A method, apparatus, and surgical technique for the modulation of autonomic function, for the purpose of treating any of several conditions and diseases, including obesity, metabolic disorders, endocrine disorders, diabetes, respiratory disease, asthma, inflammatory disease, immunological disease, infection, cancer, cardiac disease, cardiovascular disease, cerebrovascular disease, stroke, vasospasm, vascular disease, psychiatric disease, depression, affective disorders, anxiety disorders, and other conditions. This includes neural and tissue modulators, including implanted devices, used to modulate efferent and afferent autonomic neurons to influence or control autonomic or other neural function, including modulation of sympathetic and parasympathetic nervous system components as well as their combination.

Claims

1. A method for treating a medical condition by modulating the autonomic index comprising:

modulating the autonomic nervous system, said modulating comprising delivering a signal using a neuromodulator which modulates the autonomic nervous system to influence insulin level.

2. The method of claim 1 for treating a medical condition comprising:

modulating the sympathetic nervous system, said modulating comprising delivering a signal using a neuromodulator which modulates the splanchnic nerve to influence insulin level.

3. The method of claim 2 for treating a medical condition comprising:

modulating the sympathetic nervous system, said modulating comprising delivering a signal using a neuromodulator which activates the splanchnic nerve to influence insulin level.

4. The method of claim 2 for treating a medical condition comprising:

modulating the sympathetic nervous system, said modulating comprising delivering a signal using a neuromodulator which inhibits the splanchnic nerve to influence insulin level.

5. The method of claim 2 for treating a medical condition comprising:

modulating the sympathetic nervous system, said modulating comprising delivering a signal using a neuromodulator which activates and inhibits the splanchnic nerve to influence insulin level.

6. The method of claim 1 for treating a medical condition comprising:

modulating the parasympathetic nervous system, said modulating comprising delivering a signal using a neuromodulator which modulates the vagus nerve to influence insulin level.

7. The method of claim 6 for treating a medical condition comprising:

modulating the parasympathetic nervous system, said modulating comprising delivering a signal using a neuromodulator which activates the vagus nerve to influence insulin level.

8. The method of claim 6 for treating a medical condition comprising:

modulating the parasympathetic nervous system, said modulating comprising delivering a signal using a neuromodulator which inhibits the vagus nerve to influence insulin level.

9. The method of claim 6 for treating a medical condition comprising:

modulating the parasympathetic nervous system, said modulating comprising delivering a signal using a neuromodulator which activates and inhibits the vagus nerve to influence insulin level.

10. The method of claim 1 for treating a medical condition comprising:

modulating the autonomic nervous system, said modulating comprising delivering a signal using a neuromodulator which modulates the autonomic nervous system to control insulin level, wherein glucose level is controlled.

11. The method of claim 1 wherein said medical condition comprises at least one of obesity, metabolic disease, diabetes, and gastrointestinal disease.

12. A method for treating a medical condition by modulating the autonomic index comprising:

modulating the autonomic nervous system, said modulating comprising delivering a signal using a neuromodulator which modulates the autonomic nervous system to influence bronchodilation level.

13. The method of claim 12 for treating a medical condition comprising:

modulating the sympathetic nervous system, said modulating comprising delivering a signal using a neuromodulator which modulates a sympathetic nerve to influence bronchodilation level.

14. The method of claim 12 for treating a medical condition comprising:

modulating the parasympathetic nervous system, said modulating comprising delivering a signal using a neuromodulator which modulates a parasympathetic nerve to influence bronchodilation level.

15. The method of claim 12 for treating a medical condition wherein said medical condition comprises at least one of asthma, exercise induced asthma, other form of asthma, bronchoconstrictive process, bronchoconstriction, and bronchospasm.

16. A method for treating a medical condition by modulating the autonomic index comprising:

modulating the autonomic nervous system, said modulating comprising delivering a signal using a neuromodulator which modulates the autonomic nervous system to influence at least one of inflammatory response and immune response.

17. The method of claim 16 for treating a medical condition comprising:

modulating the autonomic nervous system, said modulating comprising delivering a signal using a neuromodulator which modulates the autonomic nervous system to influence inflammatory response.

18. The method of claim 17 for treating a medical condition comprising:

modulating the sympathetic nervous system, said modulating comprising delivering a signal using a neuromodulator which activates and inhibits a sympathetic nerve to influence inflammatory response.

19. The method of claim 17 for treating a medical condition comprising:

modulating the parasympathetic nervous system, said modulating comprising delivering a signal using a neuromodulator which activates and inhibits a parasympathetic nerve to influence inflammatory response.

22. The method of claim 16 for treating a medical condition comprising:

modulating the autonomic nervous system, said modulating comprising delivering a signal using a neuromodulator which modulates the autonomic nervous system to influence immune response.

23. The method of claim 16 for treating a medical condition comprising:

modulating the sympathetic nervous system, said modulating comprising delivering a signal using a neuromodulator which activates and inhibits a sympathetic nerve to influence immune response.

24. The method of claim 16 for treating a medical condition comprising:

modulating the parasympathetic nervous system, said modulating comprising delivering a signal using a neuromodulator which activates and inhibits a parasympathetic nerve to influence immune response.

20. The method of 17 wherein said medical condition comprises at least one of immunological disorder, inflammatory condition, irritable bowel syndrome, cancer, neoplastic condition, lymphoma, leukemia, primary tumor, metastatic tumor, scleroderma, dermatomyositis, myositis, vasculidities, vasculitis, eczema, organ transplant maintenance, organ transplant rejection, infection, abscess, sepsis, meningitis, human immunodeficiency virus infection, subclinical infection, asymptomatic infection, other infectious condition, and other inflammatory condition.

21. The method of 20 wherein said medical condition comprises at least one of inflammation of bronchi, inflammation of bronchioles, and inflammation of alveoli.

25. The method of 16 wherein said medical condition comprises at least one of inflammatory condition, inflammatory disease, inflammatory bowel disease, condition treatable with immunomodulation, immune disease, infection, cancer, autoimmune disease, autoimmune immunodeficiency syndrome, human immunodeficiency virus infection, severe combined immunodeficiency, other cause of immunodeficiency, other cause of immunosuppression, mitigation of effects of iatrogenic immunosuppression, mitigation of effects of iatrogenic immunosuppression for organ transplantation, mitigation of effects of iatrogenic immunosuppression for treating autoimmune disorders, other causes of decreased immune system activity, multiple sclerosis, reflex sympathetic dystrophy, diabetes, type I diabetes, rheumatoid arthritis, graft versus host disease, psoriasis, allergic reactions, dermatitis, other allergic condition, complications from infection, lyme disease, streptococcal pharyngitis, rheumatic heart disease, fungal infection, parasitic infection, bacterial infection, viral infection, other infection, exposure to infectious agent, exposure to allergenic agent, and organ transplantation.

26. A method for treating a medical condition by modulating the autonomic index comprising:

modulating the autonomic nervous system, said modulating comprising delivering a signal using a neuromodulator which modulates the autonomic nervous system to influence at least one of cardiac function and vascular function.

27. The method of claim 26 for treating a medical condition comprising:

modulating the autonomic nervous system, said modulating comprising delivering a signal using a neuromodulator which modulates the autonomic nervous system to influence cardiac function.

28. The method of claim 27 for treating a medical condition comprising:

modulating the sympathetic nervous system, said modulating comprising delivering a signal using a neuromodulator which activates and inhibits a sympathetic nerve to influence cardiac function.

29. The method of claim 27 for treating a medical condition comprising:

modulating the parasympathetic nervous system, said modulating comprising delivering a signal using a neuromodulator which activates and inhibits a parasympathetic nerve to influence cardiac function.

31. The method of claim 26 for treating a medical condition comprising:

modulating the autonomic nervous system, said modulating comprising delivering a signal using a neuromodulator which modulates the autonomic nervous system to influence vascular tone.

32. The method of claim 31 for treating a medical condition comprising:

modulating the sympathetic nervous system, said modulating comprising delivering a signal using a neuromodulator which activates and inhibits a sympathetic nerve to influence vascular tone.

33. The method of claim 31 for treating a medical condition comprising:

modulating the parasympathetic nervous system, said modulating comprising delivering a signal using a neuromodulator which activates and inhibits a parasympathetic nerve to influence vascular tone.

30. The method of 27 wherein said medical condition comprises at least one of cardiac disease, heart failure, bradycardia, decreased myocardial contractility, congestive heart failure, post myocardial infarction sequelae, other cardiac disorder, heart block, hypotension, neurogenic shock, diastolic disease, hypertension, tachycardia, and other cardiac rhythm abnormality.

34. The method of 31 wherein said medical condition comprises at least one of cerebral vasospasm, ischemic stroke, peripheral vascular disease, low blood pressure, low vascular tone, hypertension, essential hypertension, renally mediated hypertension, atherosclerosis mediated hypertension, other forms of systemic hypertension, pulmonary hypertension, coronary artery disease, peripheral vascular disease, cerebral vascular disease, myocardial infarction, stroke, application for enhanced circulation, application for enhanced drug delivery, infection, applications for enhanced circulation as an adjuvant to accelerate healing processes, ulcers, postoperative wound, trauma, headache, applications for effecting cerebral vasodilation, smoking cessation, drug withdrawal, hyperhidrosis, reflex sympathetic dystrophy, and pain.

35. A method for treating a medical condition by modulating the autonomic index comprising:

modulating the autonomic nervous system, said modulating comprising delivering a signal using a neuromodulator which modulates the autonomic nervous system to influence limbic function.

36. The method of claim 35 for treating a medical condition comprising:

modulating the sympathetic nervous system, said modulating comprising delivering a signal using a neuromodulator which activates and inhibits a sympathetic nerve to influence limbic function.

37. The method of claim 35 for treating a medical condition comprising:

modulating the parasympathetic nervous system, said modulating comprising delivering a signal using a neuromodulator which activates and inhibits a parasympathetic nerve to influence limbic function.

38. The method of claim 35 for treating a medical condition wherein said medical condition comprises at least one of psychiatric condition, depression, anxiety, agoraphobia, social anxiety, panic attacks, other neurological condition, other psychiatric conditions.